Atlas Trials

Study of PBI-200 in Subjects With NTRK-Fusion-Positive Solid Tumors

Clinical trial NCT04901806 · TERMINATED

Trial details

NCT number
NCT04901806
Sponsor
Pyramid Biosciences
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Solid Tumor, AdultBrain Tumor, PrimaryDesmoplastic Small Round Cell Tumor
Start date
2021-07-20
Primary completion
2023-07-26
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.